Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
How To Turn Ordinary Profits Into “Xcelerated” Profits
by Karim Rahemtulla, Advisory Panelist
Tuesday, September 15, 2009: Issue #1093
Most of the time, we’re no fans of Wall Street analysts. They’re often behind-the curve, biased, and flat out wrong.
But sometimes, we make exceptions – especially when their over-zealous attitude causes a stock to blast higher and hand us triple-digit gains.
I remember one such occurrence in particular with a high-tech company that we own in our Xclerated Profits Report portfolio. Thanks to some giddy CNBC analysts pumping up the price, the stock surged from $6 to $20 and we took half our position off the table for a gain of more than 100%.
The small-cap stock has suffered along with the broader market, but there’s no doubt that its business is viable. It’s leading the way in the field of touch screen and force-feedback technology – otherwise known as “haptics.” In short, this simplifies and enhances human interaction with technology in a variety of ways.
Cellphones… Games… Cars… Healthcare… This Technology is Everywhere
You’ve probably used the company’s tactile feedback technology and don’t even know it.
- For example, its technology is what causes cellphones to vibrate when they ring, or you get a message. And the company has licensed the technology to major firms like Nokia, Samsung, Motorola, and LG.
- It’s also present in video games, which gives gamers a more interactive, realistic experience, as the action on the screen is “forced” back into the controller.
- Elsewhere, it’s used in the auto industry in dashboard instruments, the casino industry in gaming machines, and the medical industry, in helping to train surgeons and doctors by replicating the behavior of the human body.
The company holds hundreds of patents and it recently signed a deal with a major chip company, a move that an influential analyst called a “game changer.”
In short, we spotted the vast potential well before Wall Street and we’re looking for another triple-digit win on the stock. And if that happens, we’ll adopt the same practice that we always do – one that you should use in your own investing…
The Name of the Game is Profits
We have a hard and fast rule at the Xcelerated Profits Report: We don’t discriminate when it comes to profits. That means if we have a winner of 100%-plus, we take our money off the table. This is true for stocks or options.
We did this last week when we sold half our shares in the gold company Golden Star Resources (NYSE: GSS) for a cool 103% gain in just a couple of months. But what makes this trade even sweeter is that we bought the shares using the proceeds from call options that we sold on another gold stock we’ve owned for a while – Yamana Gold (NYSE: AUY).
Come options expiration in January, if Yamana is trading above $6.75 per share or thereabouts (it’s currently close to $11), we’ll have essentially bought the shares of GSS for nothing.
And speaking of gold, I’ve made another play in the upcoming October Xcelerated Profits Report issue, due out at the end of this week. But it’s a play with a twist – we’re taking a “show me” stance on gold prices, arguing that gold is either going to soar or plunge from current levels. What’s more, we’ll make it do so for about $3. If you’re looking for exposure to gold, or to hedge against a price drop, you don’t want to miss it.
The bottom line is that we don’t just make picks. We take our ideas and then figure out how to turn them into “xcelerated” profits by using straightforward investment strategies that many other investors don’t know about. We teach, then we trade.
Good investing,
Karim Rahemtulla
Editor’s Note: For more details on how you can apply the Xcelerated Profits Report’s powerful strategies to your own investing, click the link to find out how to become a member for just $49 a year. When you do, you’ll also get the name of the technology play above, plus get all the latest trades like the new gold play out in just a few days.
- Why Gold Prices Could Fall From Here… And Two Ways to Play the Move
- The Strangle Options Play: When & How To Use This Trading Strategy
- The CBOE Volatility Index (VIX): Using The Fear/Greed Index to Pinpoint Your Best Time to Profit
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
![]() |
![]() |












Karim Rahemtulla is one of the country’s foremost specialists in options trading and Investment Director of Mt. Vernon Research, as well as the founder and editor of Strategic Income, The 400 Report and Investment U.
Investment U RSS Feed